tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andres Maldonado, 171 are a BUY (97.16%), 5 are a HOLD (2.84%).
Analyst Andres Maldonado, carries an average stock price target met ratio of 28.06% that have a potential upside of 39.64% achieved within 97 days.
Andres Maldonado’s has documented 339 price targets and ratings displayed on 20 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VSTM, Verastem at 05-Oct-2026.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for IBRX (IMMUNITYBIO) at 2/11/2026. The price target of $10 was fulfilled within 13 days with a profit of $3.46 (52.91%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2025
$18
$11.44 (174.39%)
$22
3 months 1 days ago
(11-Aug-2026)
0/4 (0%)
$9.96 (123.88%)
Buy Since 19-Jul-2022
$19
$12.44 (189.63%)
$19
1 years 5 months 20 days ago
(23-May-2025)
0/10 (0%)
$13.11 (222.58%)
Buy Since 25-Jul-2024
$25
$18.44 (281.10%)
$22
1 years 7 months 18 days ago
(25-Mar-2025)
0/6 (0%)
$17.92 (253.11%)
Buy Since 25-Mar-2025
$7
1 years 7 months 19 days ago
(25-Mar-2025)
1/1 (100%)
$-0.08 (-1.13%)
1
Buy Since 27-Jul-2023
$23
$16.44 (250.61%)
$20
2 years 25 days ago
(18-Oct-2024)
0/3 (0%)
$11.26 (95.91%)
Which stock is Andres Maldonado most bullish on?
Which stock is Andres Maldonado most reserved on?
